- Home
- INVE vs INCR Comparison
INVE vs INCR Comparison
Compare INVE & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVE
- INCR
- Stock Information
- Founded
- INVE 1990
- INCR 1994
- Country
- INVE United States
- INCR Israel
- Employees
- INVE N/A
- INCR N/A
- Industry
- INVE Computer peripheral equipment
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- INVE Technology
- INCR Health Care
- Exchange
- INVE Nasdaq
- INCR Nasdaq
- Market Cap
- INVE 85.9M
- INCR 82.3M
- IPO Year
- INVE 1997
- INCR N/A
- Fundamental
- Price
- INVE $3.79
- INCR $1.37
- Analyst Decision
- INVE Strong Buy
- INCR
- Analyst Count
- INVE 2
- INCR 0
- Target Price
- INVE $5.50
- INCR N/A
- AVG Volume (30 Days)
- INVE 36.3K
- INCR 32.2K
- Earning Date
- INVE 11-10-2025
- INCR 10-08-2025
- Dividend Yield
- INVE N/A
- INCR N/A
- EPS Growth
- INVE N/A
- INCR N/A
- EPS
- INVE 3.12
- INCR N/A
- Revenue
- INVE $23,538,000.00
- INCR $72,158,312.00
- Revenue This Year
- INVE N/A
- INCR $69.54
- Revenue Next Year
- INVE $9.06
- INCR $41.75
- P/E Ratio
- INVE $1.22
- INCR N/A
- Revenue Growth
- INVE N/A
- INCR N/A
- 52 Week Low
- INVE $2.86
- INCR $1.17
- 52 Week High
- INVE $4.29
- INCR $1.79
- Technical
- Relative Strength Index (RSI)
- INVE 50.32
- INCR 36.63
- Support Level
- INVE $3.71
- INCR $1.32
- Resistance Level
- INVE $4.07
- INCR $1.46
- Average True Range (ATR)
- INVE 0.21
- INCR 0.06
- MACD
- INVE -0.01
- INCR -0.01
- Stochastic Oscillator
- INVE 50.38
- INCR 19.52
About INVE Identiv Inc.
Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has one reportable segment: the IoT Business segment. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.